Abbott Laboratories
NYSE:ABT
Abbott Laboratories
Net Change in Cash
Abbott Laboratories
Net Change in Cash Peer Comparison
Competitive Net Change in Cash Analysis
Latest Figures & CAGR of Competitors
Company | Net Change in Cash | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Abbott Laboratories
NYSE:ABT
|
Net Change in Cash
$-3B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
12%
|
CAGR 10-Years
9%
|
|
Becton Dickinson and Co
NYSE:BDX
|
Net Change in Cash
$490m
|
CAGR 3-Years
-44%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Boston Scientific Corp
NYSE:BSX
|
Net Change in Cash
$-70m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
18%
|
CAGR 10-Years
N/A
|
|
Edwards Lifesciences Corp
NYSE:EW
|
Net Change in Cash
$375.4m
|
CAGR 3-Years
187%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
13%
|
|
Stryker Corp
NYSE:SYK
|
Net Change in Cash
$1.1B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
1%
|
CAGR 10-Years
N/A
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Net Change in Cash
$1.2B
|
CAGR 3-Years
37%
|
CAGR 5-Years
37%
|
CAGR 10-Years
18%
|
See Also
What is Abbott Laboratories's Net Change in Cash?
Net Change in Cash
-3B
USD
Based on the financial report for Dec 31, 2023, Abbott Laboratories's Net Change in Cash amounts to -3B USD.
What is Abbott Laboratories's Net Change in Cash growth rate?
Net Change in Cash CAGR 10Y
9%